Singapore markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
318.64+4.12 (+1.31%)
At close: 04:00PM EDT
322.45 +3.81 (+1.20%)
Pre-market: 07:15AM EDT
Full screen
Trade prices are not sourced from all markets
Previous close314.52
Bid0.00 x 800
Ask0.00 x 1200
Day's range312.43 - 320.23
52-week range261.59 - 431.79
Avg. volume254,503
Market cap8.91B
Beta (5Y monthly)0.93
PE ratio (TTM)N/A
EPS (TTM)-10.67
Earnings date01 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est343.40
  • Business Wire

    Bio-Rad to Report Second Quarter Financial Results on Thursday, August 1, 2024

    HERCULES, Calif., July 17, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the second quarter of 2024 on Thursday, August 1, 2024, following the close of the market. Management will discuss these results in a conference call scheduled for 2 PM Pacific Time (5 PM Eastern Time) that day.

  • Zacks

    Is It Wise to Hold Bio-Rad (BIO) Stock in Your Portfolio Now?

    Bio-Rad's (BIO) robust digital PCR business and Clinical Diagnostics segment raise optimism. However, macro issues raise concerns.

  • Insider Monkey

    Is Bio-Rad Laboratories (BIO) a Lucrative Investment?

    Ariel Investments, an investment management company, released its “Ariel Appreciation Fund” first-quarter 2024 investor letter. A copy of the letter can be downloaded here. The Ariel Appreciation fund increased +4.06% in the quarter, trailing the +8.23% and +8.60% returns of the Russell Midcap Value and Russell Midcap indices. Except for real estate, all sectors in the […]